Compare AU

Compare VGB vs. DRUG

Compare shares and ETFs on the ASX that you can trade on Pearler.

Vanguard Australian Government Bond Index ETF

ASX

Buy

Buy

Overview
Performance

Overview

When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Vanguard Australian Government Bond Index ETF (VGB) and the BetaShares Global Healthcare ETF - Currency Hedged (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.

Community Stats

VGB

DRUG

Popularity

Low

Low

Pearlers invested

97

63

Median incremental investment

$993.50

$967.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,956.36

$1,875.72

Average age group

26 - 35

26 - 35


Key Summary

VGB

DRUG

Strategy

VGB.AX was created on 2012-04-24 by Vanguard. The fund's investment portfolio concentrates primarily on investment grade fixed income. Vanguard Australian Government Bond Index ETF seeks to track the return of the Bloomberg AusBond Govt 0+ Yr Index before taking into account fees, expenses and tax.

DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Top 3 holdings

Australia Government Bond 3.25 2025-04-21 (3.58 %)

Australia Government Bond 0.25 2024-11-21 (3.44 %)

Australia Government Bond 4.25 2026-04-21 (3.39 %)

CHF - SWISS FRANC (0 %)

AUD - AUSTRALIA DOLLAR (0 %)

DKK - DANISH KRONE (0 %)

Top 3 industries

Other (75.53 %)

Communication Services (33.53 %)

Health Care (24.47 %)

Top 3 countries

United States (71.71 %)

Switzerland (8.14 %)

Denmark (6.30 %)

Management fee

0.2 %

0.57 %


Key Summary

VGB

DRUG

Issuer

Vanguard

BetaShares

Tracking index

Bloomberg AusBond Govt 0+ Yr Index - AUD

Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD

Asset class

ETF

ETF

Management fee

0.2 %

0.57 %

Price

$46.58

$8.12

Size

$4.694 million

$191.120 million

10Y return

-4.14 %

N/A

Annual distribution yield (5Y)

1.80 %

1.90 %

Market

ASX

ASX

First listed date

30/04/2012

08/08/2016

Purchase fee

$6.50

$6.50


Community Stats

VGB

DRUG

Popularity

Low

Low

Pearlers invested

97

63

Median incremental investment

$993.50

$967.00

Median investment frequency

Monthly

Monthly

Median total investment

$1,956.36

$1,875.72

Average age group

26 - 35

26 - 35


Pros and Cons

VGB

DRUG

Pros

  • Lower management fee

  • Higher exposure to US market

  • Higher price growth

  • Higher distribution yield

Cons

  • Lower exposure to US market

  • Lower price growth

  • Lower distribution yield

  • Higher management fee

VGB

DRUG

Lower exposure to US market

Higher exposure to US market

Lower management fee

Higher management fee

Lower price growth

Higher price growth

Lower distribution yield

Higher distribution yield

Home